Related Experiment Videos
Raising funding for early stage start-up companies
1City Technology Investment Network, London Bioscience Innovation Centre, Royal College Street, London, UK NW1 0TU. g.whitehead@citytechnet.co.uk
Drug Discovery Today
|January 28, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Hybrid Inorganic-Organic Rotaxanes and Related Compounds.
Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Structural determination of oleanane-28,13β-olide and taraxerane-28,14β-olide fluoro-lactonization products from the reaction of oleanolic acid with SelectfluorTM.
Acta crystallographica. Section E, Crystallographic communications·2024
Analysis of a Cu-Doped Metal-Organic Framework, MFM-520(Zn1-x Cux ), for NO2 Adsorption.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2023
Evolution of bismuth-based metal-organic frameworks for efficient electroreduction of CO2.
Journal of materials chemistry. A·2022
From diligence to verification: The emergence of the TechBio-Investor.
Drug discovery today·2026
Rare disease benchmarks: investment professionals' accuracy and beliefs.
Drug discovery today·2026
Exposure Robustness by Design: a translational framework for oral drug product development.
Drug discovery today·2026
Protein tags facilitate the development of bifunctional molecules.
Drug discovery today·2026
Organoids and organ-on-a-chip platforms for advancing oligonucleotide drug development.
Drug discovery today·2026
Integrating population heterogeneity in drug research and early development: a proactive strategy.
Drug discovery today·2026
Host determinants of exo-rAAV production revealed by extended gene expression analysis in HEK293 cells.
Molecular therapy. Advances·2026
Integrative machine learning and single-nucleus transcriptomics reveal MAPK-centered neuronal responses underlying the potential Alzheimer's disease risk of GenX.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026